SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-050202
Filing Date
2021-04-14
Accepted
2021-04-14 16:08:43
Documents
4
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212463-1_def14a.htm DEF 14A 617355
2 GRAPHIC lg_protagonist-pn.jpg GRAPHIC 35831
3 GRAPHIC tm212463d1-proxy_protapg1bw.jpg GRAPHIC 489062
4 GRAPHIC tm212463d1-proxy_protapg2bw.jpg GRAPHIC 374143
  Complete submission text file 0001104659-21-050202.txt   1856038
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 21825804
SIC: 2834 Pharmaceutical Preparations